Myanmar

in page functions
Total population (2012)48,724,387
Birth cohort (2012)817,829
Surviving Infants (surviving to 1 year per year, 2012)780,139
Infant mortality rate (deaths < 1 year per 1000 births, 2011)47.90/1000
Child mortality rate (deaths < 5 years per 1000 births, 2011)62.40/1000
Co-financing status (2012)Low-income
No. of districts/territories (2011)330
Download this page as a PDF factsheet

Contact GAVI

For more info, contact GAVI country representative officer or email here

GAVI support for Myanmar

Type of support

Approvals

2001-2016 (US$)
(30 Apr 2013)

Commitments

2001-2016 (US$)
(30 Apr 2013)

Disbursements

2001-2012 (US$)
(30 Apr 2013)

% Disbursed

(30 Apr 2013)
200220032004200520062007200820092010201120122013201420152016
Health System Strengthening (HSS)$10,292,641$32,780,500$8,287,57181%
HepB mono (NVS)$13,833,610$13,833,610$13,833,610100%
Immunisation Services Support (ISS)$7,707,080$7,707,080$7,707,080100%
Injection Safety Support (INS)$2,083,978$2,083,978$2,083,978100%
Measles (NVS)$1,395,500$3,114,000$1,974,774142%
Penta (NVS)$17,747,703$47,201,703$17,301,77197%
Vaccine Introduction Grant$2,518,000$2,518,000$2,518,000100%
Total$55,578,512$109,238,871$53,706,784

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

Myanmar DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2011)

Grade of Confidence		99%

*
DTP3 - Official country estimates (2011)86%
M:F sex ratio at birth (2012)1.03
Household survey: DTP3 coverage for male (2009)97.80%
Household survey: DTP3 coverage for female (2009)97.90%
Household survey: Last DTP3 survey (2009)98%
% districts achieving > 80% DTP3 coverage (2011)76%
% districts achieving < 50% DTP3 coverage (2011)3%
MCV WHO/UNICEF estimates (2011)99%
Polio WHO/UNICEF estimates (2011)99%

Breakdown of support

Non-vaccine supportVaccine support
38% 62%
$20,596,629 $33,110,155

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Myanmar

04 December 2012

GAVI Arusha FV-8s

GAVI Board reappoints Dagfinn Høybråten as chair

The GAVI Alliance Board unanimously reappointed Dagfinn Høybråten to serve a second-year term as the GAVI Board Chair.

30 November 2012

Myanmar children to benefit from pentavalent vaccine and measles second dose

To celebrate the launch of the GAVI supported pentavalent vaccine and measles second dose in Myanmar GAVI Alliance Chairman Dagfinn Høybråten and Deputy CEO Helen Evans hosted a five-day visit to the country by six politicians from Australia and New Zealand, as well as officials from WHO, UNICEF. After decades of social and political isolation half a million children in the country will now receive protection from a range of deadly diseases including measles, diphtheria, tetanus, pertussis, hepatitis B and Hib.

28 November 2012

UNICEF_2009_Bura_Indonesia copyF

02 – Intensification of routine immunisation in South-East Asia

Partners Forum 2012 - Session summary

Useful links

View all sources for data in this page
close icon

modal window here